GLUL and cancer: Yoshida et al. and Wang et al. found that MAS inhibition induces cancer cell proliferation arrest, cell cycle disruption, and ATP level reduction [11, 23], while Muthu et al. showed that it enhances drug sensitivity and apoptosis in GLUL-deficient cells [24].